论文部分内容阅读
目的探究云南白药应用于出血性胃病中的疗效。方法将2010年4月至2012年4月间于我科就诊的152例出血性胃病患者随机均分为观察组与对照组,其中观察组服用云南白药胶囊联合雷贝拉唑、阿莫西林以及克拉霉素片;对照组患者仅服用雷贝拉唑、阿莫西林和克拉霉素片,治疗两个疗程后胃镜检查愈合情况。结果观察组患者疗效优于对照组患者(P<0.05),两组不良反应较少,且无统计学差异。结论采用以雷贝拉唑为主的三联疗法加用云南白药治疗出血性胃病效果较好,患者愈合快,且不良反应率的发生较低,值得临床推广。
Objective To investigate the efficacy of Yunnan Baiyao in the treatment of hemorrhagic gastropathy. Methods A total of 152 patients with hemorrhagic gastropathy who were treated in our department from April 2010 to April 2012 were randomly divided into observation group and control group. The observation group received Yunnanbaiyao capsule combined with rabeprazole, amoxicillin and Clarithromycin tablets; control group patients taking only rabeprazole, amoxicillin and clarithromycin tablets, after two courses of gastroscopy healing. Results The efficacy of observation group was better than that of control group (P <0.05). There were few adverse reactions in two groups, and there was no significant difference. Conclusions The triple therapy with rabeprazole plus Yunnanbaiyao is effective in treating hemorrhagic gastropathy. The patients heal fast and the incidence of adverse reactions is low, which is worthy of clinical promotion.